Teixeira_2006_Rev.Bras.Psiquiatr_28_238

Reference

Title : [Apathy in Alzheimer's disease] - Teixeira_2006_Rev.Bras.Psiquiatr_28_238
Author(s) : Teixeira AL, Jr. , Caramelli P
Ref : Rev Bras Psiquiatr , 28 :238 , 2006
Abstract :

Apathy is the most common neuropsychiatry syndrome in Alzheimer's disease affecting 30-60% of patients. It can be defined as a loss of motivation and manifests in affect, cognition and behavioral changes, determining blunted emotional response, lack of insight and social retraction, respectively. In this paper, the clinical features and the therapeutic perspectives of apathy are presented. There is considerable overlap between apathy and depression in Alzheimer's disease, but both are considered discrete syndromes. Pharmacological interventions for apathy include psychostimulants, such as methylphenidate, dopaminergic agents and cholinesterase inhibitors, but the results are controversial and there is no established treatment.

PubMedSearch : Teixeira_2006_Rev.Bras.Psiquiatr_28_238
PubMedID: 16816880

Related information

Citations formats

Teixeira AL, Jr., Caramelli P (2006)
[Apathy in Alzheimer's disease]
Rev Bras Psiquiatr 28 :238

Teixeira AL, Jr., Caramelli P (2006)
Rev Bras Psiquiatr 28 :238